Perioperative Hemostasis & Transfusion Medicine Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
SECTION HEADS
-
Department of Anesthesia, University of California, San Francisco, San Francisco, CA, USA
Section Topics
- » Blood component transfusion: other
- » Blood component transfusion: plasma
- » Blood component transfusion: platelet transfusion
- » Blood component transfusion: red cell
- » Blood conservation techniques
- » Fluid therapy (incl. crystalloids, colloids and albumin)
- » Immunomodulation
- » Leukoreduction
- » Oxygen therapeutics
- » Pathogen inactivation
- » Pharmacologic therapy for hemostasis (anti-fibrinolytics, factor VIIa, etc.)
- » Special surgical aspects
- » Transfusion guidelines/consensus statements
LATEST RECOMMENDATION
Andreas Hoeft, University of Bonn, Germany. F1000 Anesthesiology & Pain Management
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
2 Recommendations, most recent by
Jean-Charles Preiser, Erasme University Hospital, Belgium. F1000 Critical Care & Emergency Medicine
- Clinical Trial
- Review / Commentary
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
